Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,610 | 29,132 | 34,911 | 42,596 | 46,045 |
| Receivables | 2,684 | 1,945 | 2,390 | 793 | 2,913 |
| TOTAL | $25,294 | $31,077 | $37,301 | $43,389 | $48,958 |
| Non-Current Assets | |||||
| PPE Net | 12,112 | 10,458 | 8,383 | 6,841 | 6,273 |
| Other Non-Current Assets | 714 | 650 | 554 | 581 | 657 |
| TOTAL | $12,826 | $11,108 | $8,937 | $7,422 | $6,930 |
| Total Assets | $38,120 | $42,185 | $46,238 | $50,811 | $55,888 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,900 | 6,214 | 5,693 | 5,527 | 4,399 |
| TOTAL | $6,900 | $6,214 | $5,693 | $5,527 | $4,399 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,143 | 1,056 | 917 | 937 | 994 |
| TOTAL | $1,143 | $1,056 | $917 | $937 | $994 |
| Total Liabilities | $8,043 | $7,270 | $6,610 | $6,464 | $5,393 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,727 | 7,651 | 7,602 | 7,594 | 7,593 |
| Common Shares | N/A | 76 | 76 | 76 | 76 |
| Retained earnings | N/A | -85,620 | -80,193 | -75,010 | -58,831 |
| Other shareholders' equity | 30,077 | 0 | 0 | 0 | 0 |
| TOTAL | $30,077 | $34,915 | $39,628 | $44,347 | $50,495 |
| Total Liabilities And Equity | $38,120 | $42,185 | $46,238 | $50,811 | $55,888 |